Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
43
AMPH Quote, Financials, Valuation and Earnings
Last price:
$26.84
Seasonality move
:
-3.24%
Day range:
$26.44 - $27.12
52-week range:
$20.39 - $39.56
Dividend yield:
0%
P/E ratio:
11.89x
P/S ratio:
1.83x
P/B ratio:
1.59x
Volume:
175.2K
Avg. volume:
406.8K
1-year change:
-29.95%
Market cap:
$1.2B
Revenue:
$732M
EPS (TTM):
$2.26
Earnings Data
Next earnings date for AMPH
Feb 25
2026
Most recent earnings per share
$0.36
Missed by $0.46
(Nov 6/2025)
Consensus Estimate
$0.83
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AMPH Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q4 | $190.5M | -- | -- | $0.92 | -- |
| 11/06/2025 | Q3 | $185.1M | $191.8M | $0.36 | $0.83 | -$0.46 |
| 08/07/2025 | Q2 | $173.2M | $174.4M | $0.64 | $0.74 | -$0.10 |
| 05/07/2025 | Q1 | $173.1M | $170.5M | $0.51 | $0.69 | -$0.18 |
| 02/27/2025 | Q4 | $188.8M | $186.5M | $0.74 | $0.94 | -$0.20 |
| 11/06/2024 | Q3 | $194.7M | $191.2M | $0.78 | $0.98 | -$0.20 |
| 08/07/2024 | Q2 | $170.9M | $182.4M | $0.73 | $0.75 | -$0.02 |
| 05/08/2024 | Q1 | $174.7M | $171.8M | $0.81 | $0.79 | $0.02 |
| 02/28/2024 | Q4 | $173.3M | $178.1M | $0.68 | $0.91 | -$0.23 |
| 11/08/2023 | Q3 | -- | -- | $0.91 | $0.69 | $0.22 |
| 08/08/2023 | Q2 | -- | -- | $0.49 | $0.56 | -$0.07 |
| 05/09/2023 | Q1 | -- | -- | $0.50 | $0.50 | $0.01 |
| 02/28/2023 | Q4 | -- | -- | $0.66 | $0.40 | $0.26 |
| 11/07/2022 | Q3 | -- | -- | $0.30 | $0.39 | -$0.09 |
| 08/08/2022 | Q2 | -- | -- | $0.33 | $0.35 | -$0.02 |
| 05/09/2022 | Q1 | -- | -- | $0.47 | $0.36 | $0.11 |
| 03/10/2022 | Q4 | -- | -- | $0.39 | $0.37 | $0.02 |
| 11/08/2021 | Q3 | -- | -- | $0.59 | $0.23 | $0.36 |
| 08/09/2021 | Q2 | -- | -- | $0.16 | $0.21 | -$0.05 |
| 05/06/2021 | Q1 | -- | -- | $0.10 | $0.18 | -$0.08 |
| 03/15/2021 | Q4 | -- | -- | -$0.13 | $0.14 | -$0.27 |
| 11/06/2020 | Q3 | -- | -- | $0.08 | $0.14 | -$0.06 |
| 08/06/2020 | Q2 | -- | -- | -$0.00 | $0.14 | -$0.14 |
| 05/07/2020 | Q1 | -- | -- | $0.08 | $0.09 | -$0.01 |
| 03/12/2020 | Q4 | -- | -- | -$0.02 | $0.08 | -$0.10 |
| 11/07/2019 | Q3 | -- | -- | $0.03 | $0.07 | -$0.04 |
| 08/07/2019 | Q2 | -- | -- | $0.08 | $0.05 | $0.03 |
| 05/09/2019 | Q1 | -- | -- | $0.10 | $0.05 | $0.05 |
| 03/12/2019 | Q4 | -- | -- | $0.13 | $0.11 | $0.02 |
| 11/08/2018 | Q3 | -- | -- | $0.12 | $0.11 | $0.01 |
| 08/08/2018 | Q2 | -- | -- | $0.03 | $0.08 | -$0.05 |
| 05/09/2018 | Q1 | -- | -- | -$0.05 | $0.08 | -$0.13 |
| 03/12/2018 | Q4 | -- | -- | $0.10 | $0.07 | $0.03 |
| 11/08/2017 | Q3 | -- | -- | $0.07 | $0.03 | $0.04 |
| 08/09/2017 | Q2 | -- | -- | $0.11 | $0.07 | $0.04 |
| 05/08/2017 | Q1 | -- | -- | $0.09 | $0.08 | $0.01 |
| 03/13/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/08/2016 | Q3 | -- | -- | $0.08 | $0.08 | -- |
| 08/08/2016 | Q2 | -- | -- | $0.14 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | $0.06 | -- | -- |
| 03/22/2016 | Q4 | -- | -- | $0.16 | -- | -- |
Amphastar Pharmaceuticals, Inc. Earnings Questions
-
How Much did Amphastar Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Amphastar Pharmaceuticals, Inc. reported $191.8M worth of top line sales in its most recent quarter.
-
Did Amphastar Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Amphastar Pharmaceuticals, Inc. announced earnings per share of $0.36 which represents a miss of analyst forecast a $0.83 per share.
-
Is Amphastar Pharmaceuticals, Inc. Profitable?
Amphastar Pharmaceuticals, Inc. reported $95M that represents $1.99 per share over the last quarter.
-
What is the Analyst Consensus for Amphastar Pharmaceuticals, Inc. EPS Next Year?
Amphastar Pharmaceuticals, Inc.'s earnings are forecast to grow from $3.06 per share to $3.87 per share next year representing an increase of 10.22%.
-
When is Amphastar Pharmaceuticals, Inc.'s Earnings Date?
Amphastar Pharmaceuticals, Inc.'s next earnings date is February 25, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
